A New Backbone for Spinal Surgery: How Cement-Ready Screws Offer Hope

PARSIPPANY, NJ – June 03, 2026 – For a growing segment of the population, the very foundation of their bodies is becoming fragile. Osteoporosis, tumors, and the simple wear of a long life can render spinal surgery a precarious endeavor, where the instruments meant to provide stability can fail in compromised bone. It’s a challenge that sits at the intersection of demographic shifts and medical technology. In response, New Jersey-based Precision Spine, Inc. has announced the launch of its Reform® Ti FS Modular Fenestrated Screw System, a technology designed to give surgeons a more robust tool for these most difficult cases.

The system addresses a fundamental problem: how to secure a screw in bone that lacks density. Traditional pedicle screws, the workhorses of spinal fusion, rely on gripping healthy bone tissue. In patients with osteoporosis or vertebrae weakened by tumors, that grip can be tenuous, risking screw loosening or pullout, which can lead to surgical failure and the need for painful, costly revisions. This new system offers a solution by turning the screw itself into a delivery device for medical-grade bone cement, creating an internal anchor to secure the hardware.

The Science of Stability

The concept, known as cement augmentation, is a feat of micro-engineering. The Reform® Ti FS screws are “fenestrated,” meaning they have small openings or windows in their shafts. Once a surgeon positions the screw within the vertebral body, polymethylmethacrylate (PMMA) bone cement is injected through the screw. It exits through three ports spaced evenly around the tip, allowing for a symmetric distribution of cement that hardens and interlocks with the surrounding cancellous bone. This creates a solid anchor, significantly increasing the force required to pull the screw out.

Dr. Stefan Renaud, an orthopedic surgeon at Caromont Regional Medical Center in North Carolina, described the technology as a “lifeline.” He noted the rising challenge of operating on an older, often malnourished population where poor bone quality is a common obstacle. “For urgent surgical needs, and for undiagnosed intraoperative osteopenia/osteoporosis there is only one currently viable option, and that is cement augmentation,” Dr. Renaud commented. “This system has worked flawlessly on dozens of cases... I have had zero loss of fixation, when using this system.”

His experience reflects a broader clinical consensus. Multiple peer-reviewed studies and meta-analyses have confirmed that fenestrated screws with cement augmentation dramatically reduce the rate of screw loosening compared to conventional screws in osteoporotic patients. The technology provides surgeons with the confidence to achieve stable fixation, even when faced with the unexpected discovery of poor bone quality mid-operation.

Addressing a Growing Unmet Need

The launch of this system is not just a technical advancement; it’s a direct response to powerful demographic tides. As people live longer, the prevalence of conditions like degenerative disc disease, spinal stenosis, and osteoporosis is climbing. These conditions often necessitate spinal fusion, and the success of such procedures hinges on the quality of the patient’s bone. Precision Spine’s new device enters a market where the demand for solutions tailored to this patient population is intensifying.

While not the first of its kind—similar systems have been on the market for several years—the introduction of another advanced option signals the industry’s deep investment in solving this problem. According to Chris DeNicola, President and CEO of Precision Spine, the system “broadens the breadth of indications that can be addressed by offering surgeons the ability to provide stabilization in compromised bone.” This expansion is critical, covering not just age-related degeneration but also stabilization after tumor resection and complex spinal deformities.

The system is also indicated for specific pediatric cases of scoliosis and, notably, for palliative care in patients with advanced-stage tumors. In these cases, where life expectancy is short, the cement-augmented screws can restore spinal integrity and relieve pain without the long wait for bone fusion to occur, offering a profound improvement in quality of life during a critical time.

Balancing Innovation with Patient Safety

As with any powerful medical technology, the benefits of cement augmentation must be weighed against its potential risks. The primary concern is cement leakage, or extravasation, where the PMMA material seeps outside the intended area. If it enters the spinal canal or contacts a nerve root, it can cause significant neurological complications. While research shows that some degree of leakage is common, occurring in a wide range of reported cases, it is overwhelmingly asymptomatic.

Mitigating this risk falls to a combination of device design and surgical skill. The design of fenestrated screws, which direct cement flow, coupled with careful, slow injection under continuous fluoroscopic imaging, allows surgeons to monitor and control the process precisely. Still, the risk underscores the importance of rigorous training and technique. Other considerations include the heat generated as the cement cures, which can potentially damage adjacent tissue, and the fact that PMMA is a permanent, non-biological implant.

These factors highlight the delicate balance inherent in modern medicine: deploying innovative tools to solve complex problems while maintaining an unwavering commitment to patient safety. The trust between patient, surgeon, and device manufacturer is built on the transparent acknowledgment of these risks and the diligent application of protocols to minimize them.

A Strategic Step for American Manufacturing

Beyond the operating room, the launch represents a strategic move for Precision Spine. By making the new system modular and compatible with its existing Reform® Ti and Reform® Ti MIS CT systems, the company provides a seamless upgrade path for hospitals and surgical centers already invested in its ecosystem. This integration simplifies inventory, reduces training time, and enhances workflow efficiency.

Furthermore, the company’s emphasis on its “Made-in-the-USA” manufacturing, with facilities in Mississippi, is a key part of its identity. In an era of fragile global supply chains, domestic production offers a promise of reliability and quality control. This philosophy is not just a marketing point but a strategic decision that resonates with a healthcare system increasingly focused on resilience and accountability.

By adding this advanced capability to its portfolio, the company strengthens its position in the competitive spinal device market, demonstrating a commitment to addressing the evolving needs of both surgeons and their most challenging patients.